New Treatments Emerge for Obstructive Sleep Apnea, Redefining Care

Obstructive Sleep Apnea (OSA) is a prevalent chronic condition characterized by recurrent episodes of upper airway collapse during sleep, leading to intermittent hypoxia and sleep fragmentation. It significantly impacts quality of life and is strongly associated with serious comorbidities like cardiovascular disease, hypertension, diabetes, and stroke. While continuous positive airway pressure (CPAP) remains the gold standard, its adherence rates are often suboptimal, highlighting a critical need for diverse and more personalized treatment options beyond traditional mechanical ventilation.